Short-Term Immunogenicity Profiles and Predictors for Suboptimal Immune Responses in Patients with End-Stage Kidney Disease Immunized with Inactivated SARS-CoV-2 Vaccine-Reference-Cited by-同舟云学术

Short-Term Immunogenicity Profiles and Predictors for Suboptimal Immune Responses in Patients with End-Stage Kidney Disease Immunized with Inactivated SARS-CoV-2 Vaccine

Published:2021-12-03 Issue: Volume: Page:
ISSN:2193-8229
Container-title:Infectious Diseases and Therapy
language:en
Short-container-title:Infect Dis Ther

Author:

Boongird Sarinya,Chuengsaman Piyatida,Setthaudom Chavachol,Nongnuch Arkom,Assanatham Montira,Phanprasert Salinnart,Kitpermkiat Rungthiwa,Kiertiburanakul Sasisopin,Malathum Kumthorn,Phuphuakrat Angsana,Davenport Andrew,Bruminhent Jackrapong^ORCID

Funder

National Research Council of Thailand

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40121-021-00574-9.pdf

Reference29 articles.

1. Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430–6. https://doi.org/10.1038/s41586-020-2521-4.

2. Jager KJ, Kramer A, Chesnaye NC, et al. Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe. Kidney Int. 2020;98(6):1540–8.

3. Carr EJ, Kronbichler A, Graham-Brown M, et al. Review of early immune response to SARS-CoV-2 vaccination among patients with CKD. Kidney Int Rep. 2021;6(9):2292–304. https://doi.org/10.1016/j.ekir.2021.06.027.

4. Yanay NB, Freiman S, Shapira M, et al. Experience with SARS-CoV-2 BNT162b2 mRNA vaccine in dialysis patients. Kidney Int. 2021;99(6):1496–8. https://doi.org/10.1016/j.kint.2021.04.006.

5. Stumpf J, Siepmann T, Lindner T, et al. Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: a prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine. Lancet Reg Health Eur. 2021;9: 100178. https://doi.org/10.1016/j.lanepe.2021.100178.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of homologous and heterologous inactivated and mRNA vaccination programme against SARS‐CoV‐2 in dialysis patients;Nephrology;2024-03-14

2. COVID-19 and outcomes in Chinese peritoneal dialysis patients;Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis;2024-01-24

3. Outcomes of vaccinations against respiratory diseases in patients with end-stage renal disease undergoing hemodialysis: A systematic review and meta-analysis;PLOS ONE;2023-02-09

4. Humoral Response to BNT162b2 and CoronaVac in Patients Undergoing Maintenance Hemodialysis: A Multicenter Prospective Cohort Study;Nephron;2023

5. Membranous Nephropathy following Full-Dose of Inactivated SARS-CoV-2 Virus Vaccination: A Case Report and Literature Review;Vaccines;2022-12-29